UK-produced medicines produced L2.25 billion ($3.65 billion) worth ofoverseas earnings in 1996, up 6% on 1995, says the Association of the British Pharmaceutical Industry.
UK drug industry exports rose 9% to L5.36 billion ($8.70 billion) last year. However, imports were up 11% to L3.11 billion ($5.04 billion). The rise in imports was noted by ABPI director-general Trevor Jones, who said it provided "a timely reminder" to the new Labour government that "the industry requires a stable environment if it is to continue to make such a major input to the health and wealth of the nation."
The ABPI also notes that the balance of UK drug exports to other European Union countries rose 65% in 1996. With exports of $2.94 billion and imports at $2.05 billion, the trade balance was L896 million compared to L542 million in 1995.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze